In addition to its inhibitory effects on ERK and/or p38 MAP kinase [37,44,66], alantolactone has been shown to increase the phosphorylation of ERK and p38 MAP kinase in human breast, gastric, and colon cancer cells [41,42,67,68]. The gene discussed is MAPK14; the disease is malignant colon neoplasm.